講師資料
Talks：
Obesity related OSA: From Weight Management to Integrated Treatment Strategy with Mounjaro®
Name：
徐英碩（Ying-Shuo Hsu）
Position：
1. Attending Physician, Department of Otolaryngology
2. Researcher, Institute of Brain Science
3. Vice Chair, Sleep Surgery Committee
Affiliation：
1. Shin Kong Wu Ho-Su Memorial Hospital
2. National Yang Ming Chiao Tung University
3. Taiwan Society of Sleep Medicine
Email：
Photo：
Research Interests：
Surgery and treatment of obstructive sleep apnea; interventional target-controlled-infusion drug-induced sleep endoscopy (TCI-DISE) for upper-airway phenotyping.
Selected Publications：
1. Hsu YS, Ke YK, Kuo TBJ, et al. Expiratory Velopharyngeal Obstruction: Sleep Endoscopy-Guided Treatment Strategies to Prevent Oral Breathing During Sleep. Otolaryngol Head Neck Surg. 2024;171(5):1591-1600. doi:10.1002/ohn.902
2. Chung SL, Chen CT, Wang CT, et al. Weakly Supervised Learning Applied for Airway Patency Identification in Drug-Induced Sleep Endoscopy Videos. In: 2024 International Joint Conference on Neural Networks (IJCNN). IEEE; 2024:1-8. doi:10.1109/IJCNN60899.2024.10650409
3. Lin HC, Wang CH, Kuo TBJ, et al. Upper Airway Surgery or Weight Control? Modified Drug-Induced Sleep Endoscopy for Obstructive Sleep Apnea. Otolaryngol Head Neck Surg. 2023;169(5):1345-1355. doi:10.1002/ohn.364
4. Shih HW, Chen YL, Lin HC, et al. Potential Treatments for Epiglottic Collapse in Obstructive Sleep Apnea: How Modified Drug-Induced Sleep Endoscopy Help? Otolaryngol Head Neck Surg. Published online November 23, 2023. doi:10.1002/ohn.572
5. Chiu FH, Chang Y, Liao WW, et al. Post-Operative Sleep Endoscopy with Target-Controlled Infusion After Palatopharyngoplasty for Obstructive Sleep Apnea: Anatomical and Polysomnographic Outcomes. Nat Sci Sleep. 2021;13:1181-1193. doi:10.2147/NSS.S311702
Abstract：
阻塞性睡眠呼吸中止症（OSA）是一種與肥胖、代謝異常及心血管疾病密切相關的慢性疾病。近年研究顯示，肥胖不僅是 OSA 的重要危險因子，更是疾病發生與惡化的關鍵病理驅動因子，因此體重管理的重要性已逐漸由生活型態建議提升為治療策略的一環。
本演講將探討肥胖與 OSA 之間的病理生理機轉、現行治療模式的限制，以及體重管理在 obesity-related OSA 整合照護中的角色。同時分享近期臨床研究證據，說明體重下降對 OSA 嚴重度、睡眠相關症狀及心血管代謝指標的影響，並進一步討論如何將相關證據應用於臨床實務，以提升肥胖相關 OSA 病人的長期治療成效與整體健康結果。
2026年會：